Jpmorgan Chase & CO Fulcrum Therapeutics, Inc. Put Options Transaction History
Jpmorgan Chase & CO
- $1.14 Trillion
- Q2 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding FULC
# of Institutions
136Shares Held
59.1MCall Options Held
4.33MPut Options Held
309K-
Ra Capital Management, L.P. Boston, MA11.6MShares$37.8 Million1.08% of portfolio
-
Rtw Investments, LP New York, NY5.85MShares$19.1 Million0.61% of portfolio
-
Black Rock Inc. New York, NY4.8MShares$15.6 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.07MShares$10 Million0.0% of portfolio
-
Cowen And Company, LLC2.96MShares$9.66 Million0.47% of portfolio
About Fulcrum Therapeutics, Inc.
- Ticker FULC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 52,038,900
- Market Cap $170M
- Description
- Fulcrum Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing products for improving the lives of patients with genetically defined diseases in the areas of high unmet medical need in the United States. Its product candidates are losmapimod, a small molecule for the treatment of facioscapulohumeral muscular dystro...